Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,8694198,Abfw3,Abdominal fat weight QTL 3,16.13,0.001,visceral adipose mass (VT:0010063),abdominal fat pad weight to body weight ratio (CMO:0000095),5,116767924,161767924,Rat,n/a,region,qtl 1000,1641912,Alcrsp18,Alcohol response QTL 18,,,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),5,35788756,147487820,Rat,n/a,region,qtl 1000,2306971,Anxrr21,Anxiety related response QTL 21,9.47,,fear/anxiety-related behavior trait (VT:1000241),number of entries into a discrete space in an experimental apparatus (CMO:0000960),5,65696672,129038896,Rat,n/a,region,qtl 1000,738018,Anxrr4,Anxiety related response QTL 4,5.1,,exploratory behavior trait (VT:0010471),percentage of entries into a discrete space in an experimental apparatus (CMO:0000961),5,136354114,173707219,Rat,n/a,region,qtl 1000,631562,Apr2,Acute phase response QTL 2,3.7,,blood murinoglobulin 1 amount (VT:0010597),plasma murinoglobulin 1 level (CMO:0001931),5,142307322,173707219,Rat,n/a,region,qtl 1000,1578673,Bmd13,Bone mineral density QTL 13,4.9,,femur mineral mass (VT:0010011),trabecular volumetric bone mineral density (CMO:0001729),5,107119214,152119214,Rat,n/a,region,qtl 1000,2313096,Bmd78,Bone mineral density QTL 78,3.1,0.0001,tibia mineral mass (VT:1000283),total volumetric bone mineral density (CMO:0001728),5,150360936,167946134,Rat,n/a,region,qtl 1000,631505,Bp103,Blood pressure QTL 103,3.2,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,138154677,172402610,Rat,n/a,region,qtl 1000,634349,Bp139,Blood pressure QTL 139,,0.001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,134197905,173707219,Rat,n/a,region,qtl 1000,724525,Bp147,Blood pressure QTL 147,4.3,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,132551937,173707219,Rat,n/a,region,qtl 1000,1298090,Bp155,Blood pressure QTL 155,3.8,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),5,157212422,167739539,Rat,n/a,region,qtl 1000,1298086,Bp156,Blood pressure QTL 156,,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,89502294,134502294,Rat,n/a,region,qtl 1000,1300119,Bp180,Blood pressure QTL 180,3.82,,arterial blood pressure trait (VT:2000000),blood pressure time series experimental set point of the baroreceptor response (CMO:0002593),5,150340838,164298744,Rat,n/a,region,qtl 1000,1331721,Bp210,Blood pressure QTL 210,3.413,,arterial blood pressure trait (VT:2000000),blood pressure time series experimental set point of the baroreceptor response (CMO:0002593),5,149029982,173687766,Rat,n/a,region,qtl 1000,1358895,Bp254,Blood pressure QTL 254,3.6,0.0003,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),5,60072951,133313852,Rat,n/a,region,qtl 1000,1358889,Bp261,Blood pressure QTL 261,2.86,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),5,93037304,133313852,Rat,n/a,region,qtl 1000,1598819,Bp292,Blood pressure QTL 292,4.3,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,133943857,173707219,Rat,n/a,region,qtl 1000,1598846,Bp293,Blood pressure QTL 293,3.9,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,83424556,128424556,Rat,n/a,region,qtl 1000,7365049,Bp359,Blood pressure QTL 359,,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,133351969,140120264,Rat,n/a,region,qtl 1000,61393,Bp7,Blood pressure QTL 7,4.5,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,61612600,168109659,Rat,n/a,region,qtl 1000,7207481,Bss106,Bone structure and strength QTL 106,7.9,,femur strength trait (VT:0010010),femur ultimate force (CMO:0001675),5,112279412,157279412,Rat,n/a,region,qtl 1000,7207486,Bss109,Bone structure and strength QTL 109,,,femur strength trait (VT:0010010),femur total energy absorbed before break (CMO:0001677),5,112279412,157279412,Rat,n/a,region,qtl 1000,7207488,Bss110,Bone structure and strength QTL 1,8.4,,femur strength trait (VT:0010010),femur stiffness (CMO:0001674),5,112279412,157279412,Rat,n/a,region,qtl 1000,7207491,Bss112,Bone structure and strength QTL 112,7,,femur morphology trait (VT:0000559),femur midshaft cortical cross-sectional area (CMO:0001663),5,112279412,157279412,Rat,n/a,region,qtl 1000,11528624,Bss114,Bone structure and strength QTL 114,6.54,0.000000287,femur strength trait (VT:0010010),femur total energy absorbed before break (CMO:0001677),5,129335618,131897286,Rat,n/a,region,qtl 1000,2293642,Bss37,Bone structure and strength QTL 37,4.64,0.0001,femur strength trait (VT:0010010),femur ultimate force (CMO:0001675),5,125455818,157225114,Rat,n/a,region,qtl 1000,1549838,Bss4,Bone structure and strength QTL 4,9.2,,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),5,112279412,157279412,Rat,n/a,region,qtl 1000,6903316,Bw113,Body weight QTL 113,2,0.0103,body mass (VT:0001259),body weight (CMO:0000012),5,91884213,136884213,Rat,n/a,region,qtl 1000,7411564,Bw135,Body weight QTL 135,,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),5,91585539,136585539,Rat,n/a,region,qtl 1000,8657050,Bw146,Body weight QTL 146,19.84,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),5,113059816,120566842,Rat,n/a,region,qtl 1000,8694169,Bw148,Body weight QTL 148,5,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),5,134712342,173707219,Rat,n/a,region,qtl 1000,8694389,Bw160,Body weight QTL 160,6.17,0.001,body lean mass (VT:0010483),lean tissue morphological measurement (CMO:0002184),5,116767924,161767924,Rat,n/a,region,qtl 1000,8694441,Bw169,Body weight QTL 169,17.61,0.001,retroperitoneal fat pad mass (VT:0010430),retroperitoneal fat pad weight to body weight ratio (CMO:0000635),5,116767924,161767924,Rat,n/a,region,qtl 1000,1582230,Bw78,Body weight QTL 78,3.2,0.0016,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),5,123852489,133313852,Rat,n/a,region,qtl 1000,61452,Ciaa5,CIA Autoantibody QTL 5,3.5,,blood autoantibody amount (VT:0003725),calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281),5,97921932,149030144,Rat,n/a,region,qtl 1000,631263,Cm24,Cardiac mass QTL 24,3.5,,heart mass (VT:0007028),heart left ventricle weight to body weight ratio (CMO:0000530),5,149832180,164807402,Rat,n/a,region,qtl 1000,1581510,Cm54,Cardiac mass QTL 54,3.4,0.05,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),5,125455818,149568944,Rat,n/a,region,qtl 1000,1598847,Cm62,Cardiac mass QTL 62,3.4,,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),5,114140832,159140832,Rat,n/a,region,qtl 1000,1598861,Cm64,Cardiac mass QTL 64,2.9,,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),5,133943857,173707219,Rat,n/a,region,qtl 1000,1598859,Cm66,Cardiac mass QTL 66,2,,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),5,83424556,128424556,Rat,n/a,region,qtl 1000,1641920,Colcs1,Colorectal carcinoma susceptibility QTL 1,2.99,0.0055,intestine integrity trait (VT:0010554),benign colorectal tumor surface area measurement (CMO:0001799),5,128687766,173687766,Rat,n/a,region,qtl 1000,1358187,Emca1,Estrogen-induced mammary cancer QTL 1,4.4,,mammary gland integrity trait (VT:0010552),post-insult time to mammary tumor formation (CMO:0000345),5,102945579,154732228,Rat,n/a,region,qtl 1000,7394708,Emca11,Estrogen-induced mammary cancer QTL 11,,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,103580245,117037276,Rat,n/a,region,qtl 1000,7394710,Emca12,Estrogen-induced mammary cancer QTL 12,,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,129038716,139099229,Rat,n/a,region,qtl 1000,1576312,Emca8,Estrogen-induced mammary cancer QTL 8,4.1,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,51418671,147487820,Rat,n/a,region,qtl 1000,7411601,Foco12,Food consumption QTL 12,19.7,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),5,91585539,136585539,Rat,n/a,region,qtl 1000,7411582,Foco3,Food consumption QTL 3,7.5,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),5,91585539,136585539,Rat,n/a,region,qtl 1000,2317753,Glom24,Glomerulus QTL 24,3.1,,kidney glomerulus integrity trait (VT:0010546),kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269),5,101265591,141912026,Rat,n/a,region,qtl 1000,2316959,Gluco59,Glucose level QTL 59,4.7,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),5,35661945,117554267,Rat,n/a,region,qtl 1000,1358909,Kidm25,Kidney mass QTL 25,1.87,,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),5,93037304,133313852,Rat,n/a,region,qtl 1000,631272,Lanf1,Left ventricular atrial natriuretic factor QTL 1,12,,heart left ventricle natriuretic peptide A amount (VT:0010596),heart left ventricle natriuretic peptide A level (CMO:0002165),5,157319671,173707219,Rat,n/a,region,qtl 1000,1582212,Livw2,Liver weight QTL 2,3.5,0.0004,liver mass (VT:0003402),liver weight as percentage of body weight (CMO:0000141),5,102498468,123852688,Rat,n/a,region,qtl 1000,634305,Mamtr1,Mammary tumor resistance QTL 1,,0.0001,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,12651967,117554267,Rat,n/a,region,qtl 1000,7794791,Mcs33,Mammary carcinoma susceptibility QTL 33,1.93,,mammary gland integrity trait (VT:0010552),mammary tumor incidence/prevalence measurement (CMO:0000946),5,136640731,173707219,Rat,n/a,region,qtl 1000,70189,Mcs5,Mammary carcinoma susceptibility QTL 5,10.51,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),5,56991667,137729065,Rat,n/a,region,qtl 1000,1549904,Neuinf1,Neuroinflammation QTL 1,3,0,nervous system integrity trait (VT:0010566),blood T lymphocyte count (CMO:0000110),5,161084664,173707219,Rat,n/a,region,qtl 1000,70212,Niddm25,Non-insulin dependent diabetes mellitus QTL 25,3.54,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),5,1,136640934,Rat,n/a,region,qtl 1000,70156,Niddm30,Non-insulin dependent diabetes mellitus QTL 30,3.98,,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),5,134502140,157212422,Rat,n/a,region,qtl 1000,8552960,Pigfal15,Plasma insulin-like growth factor 1 level QTL 15,,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),5,116767924,161767924,Rat,n/a,region,qtl 1000,8552908,Pigfal4,Plasma insulin-like growth factor 1 level QTL 4,6.6,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),5,134712342,173707219,Rat,n/a,region,qtl 1000,2316957,Pur21,Proteinuria QTL 21,6.2,,urine protein amount (VT:0005160),urine protein level (CMO:0000591),5,61086653,117554114,Rat,n/a,region,qtl 1000,1331803,Rf32,Renal function QTL 32,2.798,,kidney blood vessel physiology trait (VT:0100012),absolute change in renal vascular resistance (CMO:0001900),5,134502121,149030144,Rat,n/a,region,qtl 1000,1331801,Rf33,Renal function QTL 33,4.149,,kidney blood vessel physiology trait (VT:0100012),absolute change in renal vascular resistance (CMO:0001900),5,44404276,134502294,Rat,n/a,region,qtl 1000,1581505,Rf54,Renal function QTL 54,,,kidney physiology trait (VT:0002136),kidney 20-HETE level (CMO:0001854),5,133313668,138454239,Rat,n/a,region,qtl 1000,1298089,Scl14,Serum cholesterol level QTL 14,5.8,0.0004,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,114140832,159140832,Rat,n/a,region,qtl 1000,1298070,Scl18,Serum cholesterol level QTL 18,3.7,,blood LDL cholesterol amount (VT:0000181),calculated plasma low density lipoprotein cholesterol level (CMO:0001245),5,83424556,128424556,Rat,n/a,region,qtl 1000,61426,Scl2,Serum cholesterol level QTL 2,7.3,0.001,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),5,61086525,149030144,Rat,n/a,region,qtl 1000,1302790,Scl20,Serum cholesterol level QTL 20,6.4,0.0001,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,84963058,173504662,Rat,n/a,region,qtl 1000,1549845,Scl44,Serum cholesterol level QTL 44,6,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),5,40777918,154732375,Rat,n/a,region,qtl 1000,2290448,Scl54,Serum cholesterol level QTL 54,2.93,,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,31926122,136640934,Rat,n/a,region,qtl 1000,2302369,Scl60,Serum cholesterol level QTL 60,3.13,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),5,149568588,167739697,Rat,n/a,region,qtl 1000,10053720,Scort26,Serum corticosterone level QTL 26,2.06,0.0147,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),5,131077716,173707219,Rat,n/a,region,qtl 1000,1354598,Srn6,Serum renin concentration QTL 6,3.8,,blood renin amount (VT:0003349),plasma renin activity level (CMO:0000116),5,71552569,157225114,Rat,n/a,region,qtl 1000,61444,Strs2,Sensitivity to stroke QTL 2,4.7,,cerebrum integrity trait (VT:0010549),post-insult time to onset of cerebrovascular lesion (CMO:0002343),5,142309061,173707219,Rat,n/a,region,qtl 1000,7411722,Strs6,Sensitivity to stroke QTL 6,3.9,,cerebrum integrity trait (VT:0010549),percentage of study population developing cerebrovascular lesions during a period of time (CMO:0000932),5,140387005,143846157,Rat,n/a,region,qtl 1000,1354631,Swd2,Spike wave discharge measurement QTL 2,3.64,0.0002,brain electrophysiology trait (VT:0010557),brain total spike-and-wave discharge duration (CMO:0001740),5,157319671,171194163,Rat,n/a,region,qtl 1000,1578766,Tcas11,Tongue tumor susceptibility QTL 11,4.12,,tongue integrity trait (VT:0010553),number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950),5,47745646,167946134,Rat,n/a,region,qtl 1000,1331796,Thshl2,Thyroid stimulating hormone level QTL 2,2.3,,blood thyroid-stimulating hormone amount (VT:0005119),serum thyroid stimulating hormone level (CMO:0001248),5,100723739,153577831,Rat,n/a,region,qtl 1000,631527,Tls1,T-lymphoma susceptibility QTL 1,0,0.001,thymus integrity trait (VT:0010555),post-insult time to onset of T-cell lymphoma (CMO:0001907),5,93273130,138273130,Rat,n/a,region,qtl 1000,1300122,Wbc1,White blood cell count QTL 1,2.75,,leukocyte quantity (VT:0000217),total white blood cell count (CMO:0000365),5,130531300,145726262,Rat,n/a,region,qtl 1000,2317056,Wbc3,White blood cell count QTL 3,2.51,0.01,leukocyte quantity (VT:0000217),white blood cell count (CMO:0000027),5,111278451,156278451,Rat,n/a,region,qtl